The Bill & Melinda Gates Foundation has awarded $3.28 million to Seventh Sense Biosystems as part of a foundation program that is intended to increase developing countries' access to diagnostic tools. The company will use the money to develop a version of its Touch Activated Phlebotomy device that allows the collection of more blood.
Mass. diagnostics firm wins $3.28M from Gates Foundation
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||